[Signal averaged electrocardiogram of the P wave after reduction of permanent atrial fibrillation. A comparison with results obtained in healthy subjects and in patients with atrial fibrillation].
Signal averaging of the ECG P wave is a recent technique used for obtaining predictive and prognostic information in atrial arrhythmias. There have been few publications of its evaluation in this setting. The authors report their results of temporal analysis of the P wave of patients who had undergone electrical cardioversion of atrial fibrillation (group 3, n = 22 patients) and compared them with those of a control group without atrial arrhythmias (group 1, n = 25 patients). After recording signals in three bipolar leads (Predictor 5.0 II Corazonix recorder-analyser), the total duration of the P wave, the root mean square of the P wave amplitude (RMSt) and of the last 20 milliseconds (RMS 20) and the integral under the curve of the P waves (IN) were determined. The comparison was continued with data obtained from a population of patients with paroxysmal atrial fibrillation (group 2, n = 22). All patients had normal left atria on echocardiography, had no valvular heart disease, had no myocardial infarction or signs of cardiac failure. Results showed that the most discriminating parameter was the P wave duration (Group 3: 159.45 +/- 15.1 ms; group 1: 123 +/- 8.5 ms; group 2: 144.6 +/- 12.03 ms; group 1 versus group 2, p < 0.001, group 2 versus group 3, p < 0.01; group 1 versus group 3, p < 0.0001).(ABSTRACT TRUNCATED AT 250 WORDS)
Chauvin
M
M
Service de cardiologie, hôpital du CMCO, Schiltigheim.
Brechenmacher
C
C
D000669:Amplifiers, Electronic; D001281:Atrial Fibrillation / Q000503:physiopathology* / Q000628:therapy; D002985:Clinical Protocols; D004554:Electric Countershock; D004562:Electrocardiography / Q000379:methods*; D006801:Humans; D011237:Predictive Value of Tests; D011379:Prognosis
Electrocardiogramme moyenné de l'onde P après réduction d'une fibrillation auriculaire permanente. Comparaison avec les résultats obtenus chez des sujets sains ou victimes de fibrillation auriculaire paroxystique.